163
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Antibacterial Potential of Trihydroxycyclohexa-2,4-Diene-1-Carboxylic Acid: Insight from DFT, Molecular Docking, and Molecular Dynamic Simulation

, , , , , , , , , , , & show all
Pages 2128-2151 | Received 02 Nov 2022, Accepted 07 May 2023, Published online: 22 May 2023

References

  • J. Holmgren, “Actions of Cholera Toxin and the Prevention and Treatment of Cholera,” Nature 292, no. 5822 (1981): 413–417.
  • M. Ali, A.L. Lopez, Y. You, Y.E. Kim, B. Sah, B. Maskery, and J. Clemens, “The Global Burden of Cholera,” Bulletin of the World Health Organization 90, no. 3 (2012): 209–218A.
  • C.L. Briggs, “Stories in the Time of Cholera,” In Stories in the Time of Cholera (University of California Press, 2003).
  • C.E. Rosenberg, The Cholera Years: The United States in 1832, 1849, and 1866 (University of Chicago Press, 2009).
  • C. Seas, H.L. DuPont, L.M. Valdez, and E. Gotuzzo, “Practical Guidelines for the Treatment of Cholera,” Drugs 51, no. 6 (1996): 966–973.
  • L. Odevall, D. Hong, L. Digilio, S. Sahastrabuddhe, V. Mogasale, Y. Baik, S. Choi, J.H. Kim, and J. Lynch, “The Euvichol Story–Development and Licensure of a Safe, Effective and Affordable Oral Cholera Vaccine through Global Public Private Partnerships,” Vaccine 36, no. 45 (2018): 6606–6614.
  • F.B. Sousa, I.R. Nolêto, L.S. Chaves, G. Pacheco, A.P. Oliveira, M.M. Fonseca, and J.V. Medeiros, “A Comprehensive Review of Therapeutic Approaches Available for the Treatment of Cholera,” The Journal of Pharmacy and Pharmacology 72, no. 12 (2020): 1715–1731.
  • R.V. Tauxe and P.A. Blake, “Epidemic Cholera in Latin America,” JAMA 267, no. 10 (1992): 1388–1390.
  • K.M. Pandya, S. Battula, and P.J. Naik, “Pd-Catalyzed post-Ugi Intramolecular Cyclization to the Synthesis of Isoquinolone-Pyrazole Hybrid Pharmacophores & Discover Their Antimicrobial and DFT Studies,” Tetrahedron Letters 81 (2021): 153353.
  • D.R. Leenaraj and I.H. Joe, “Non-Opioid Analgesic Drug Flupirtine: Spectral Analysis, DFT Computations, in Vitro Bioactivity and Molecular Docking Study,” Chemical Physics Letters 677 (2017): 41–49.
  • A.K. Sarangi, B.B. Mahapatra, R.K. Mohapatra, S.K. Sethy, D. Das, L. Pintilie, M. Kudrat‐E‐Zahan, M. Azam, and H. Meher, “Synthesis and Characterization of Some Binuclear Metal Complexes with a Pentadentate Azodye Ligand: An Experimental and Theoretical Study,” Applied Organometallic Chemistry 34, no. 8 (2020): E 5693.
  • M. Ahmadi, C. Fischer, A.C. Ghosh, and C. Schulzke, “An Asymmetrically Substituted Aliphatic Bis-Dithiolene Mono-Oxido Molybdenum (IV) Complex with Ester and Alcohol Functions as Structural and Functional Active Site Model of Molybdoenzymes,” Frontiers in Chemistry 7 (2019): 486.
  • P. Provencher, “Synthesis and Performance of an Alkylating Agent Sensor” (Doctoral dissertation, University of British Columbia, 2014).
  • I.J. Košir, B. Lapornik, S. Andrenšek, A.G. Wondra, U. Vrhovšek, and J. Kidrič, “Identification of Anthocyanins in Wines by Liquid Chromatography, Liquid Chromatography-Mass Spectrometry and Nuclear Magnetic Resonance,” Analytica Chimica Acta 513, no. 1 (2004): 277–282.
  • H. Fernando, S. Kondraganti, K.K. Bhopale, D.E. Volk, M. Neerathilingam, B.S. Kaphalia, B.A. Luxon, P.J. Boor, and G.A. Shakeel Ansari, “1H and 31P NMR Lipidome of Ethanol‐Induced Fatty Liver,” Alcoholism, Clinical and Experimental Research 34, no. 11 (2010): 1937–1947.
  • R. Consonni and L.R. Cagliani, “The Potentiality of NMR‐Based Metabolomics in Food Science and Food Authentication Assessment,” Magnetic Resonance in Chemistry 57, no. 9 (2019): 558–578.
  • J.D. Chai and M. Head-Gordon, “Long-Range Corrected Hybrid Density Functionals with Damped Atom–Atom Dispersion Corrections,” Physical Chemistry Chemical Physics 10, no. 44 (2008): 6615–6620.
  • Y. Zhao and D.G. Truhlar, “Theo Chem Acc. 2008; 120: 215.[Google Scholar](b) Zhao Y, Truhlar DG,” Accounts of Chemical Research 41, no. 2 (2008): 157–167.
  • A.D. Becke, “Density-Functional Exchange-Energy Approximation with Correct Asymptotic Behavior,” Physical Review. A, General Physics 38, no. 6 (1988): 3098–3100.
  • J. Heyd, G.E. Scuseria, and M. Ernzerhof, “Hybrid Functionals Based on a Screened Coulomb Potential,” The Journal of Chemical Physics 118, no. 18 (2003): 8207–8215.
  • B.L. Jejurikar and S.H. Rohane, “Drug Designing in Discovery Studio,” Asian J Res Chem 14, no. 2 (2021): 135–138.
  • G.A. Zhurko and D.A. Zhurko, “ChemCraft, version 1.6,” 2009, http://www. chemcraftprog. com.
  • A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 1 (2017): 1–13.
  • W.P. Walters, “Going Further than Lipinski’s Rule in Drug Design,” Expert Opinion on Drug Discovery 7, no. 2 (2012): 99–107.
  • A.K. Ghose, V.N. Viswanadhan, and J.J. Wendoloski, “A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases,” Journal of Combinatorial Chemistry 1, no. 1 (1999): 55–68.
  • D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple, “Molec?ular Properties That Influence the Oral Bioavailability of Drug Candidates,” Journal of Medicinal Chemistry 45, no. 12 (2002): 2615–2623.
  • W.J. Egan, K.M. Merz, and J.J. Baldwin, “Prediction of Drug Absorption Using Multivariate Statistics,” Journal of Medicinal Chemistry 43, no. 21 (2000): 3867–3877.
  • P. Banerjee, A.O. Eckert, A.K. Schrey, and R. Preissner, “ProTox-II: A Webserver for the Prediction of Toxicity of Chemicals,” Nucleic Acids Research 46 (2018): W257–W263.
  • J.B. Heim, V. Hodnik, J.E. Heggelund, G. Anderluh, and U. Krengel, “Crystal Structures of Cholera Toxin in Complex with Fucosylated Receptors Point to Importance of Secondary Binding site,” Scientific Reports 9, no. 1 (2019): 1–14.
  • J.F. Couture, E. Collazo, and R.C. Trievel, “Molecular Recognition of Histone H3 by the WD40 Protein WDR5,” Nature Structural & Molecular Biology 13, no. 8 (2006): 698–703.
  • P.D. Bank, “Research Collaboratory for Structural Bioinformatics,” 2018, http://www. tcsb. org/pdb/.
  • K.T. Batty, T.M. Davis, K.F. Ilett, L.J. Dusci, and S.R. Langton, “The Effect of Ciprofloxacin on Theophylline Pharmacokinetics in Healthy Subjects,” British Journal of Clinical Pharmacology 39, no. 3 (1995): 305–311.
  • D.S. Wishart, Y.D. Feunang, A.C. Guo, E.J. Lo, A. Marcu, J.R. Grant, T. Sajed, D. Johnson, C. Li, Z. Sayeeda, et al. “DrugBank 5.0: A Major Update to the DrugBank Database for 2018,” Nucleic Acids Research 46 (2018): D1074–D1082.
  • N.T. Nguyen, T.H. Nguyen, T.N.H. Pham, N.T. Huy, M.V. Bay, M.Q. Pham, P.C. Nam, V.V. Vu, and S.T. Ngo, “Autodock Vina Adopts More Accurate Binding Poses but autodock4 Forms Better Binding Affinity,” Journal of Chemical Information and Modeling 60, no. 1 (2020): 204–211.
  • W.L. DeLano, “Pymol: An Open-Source Molecular Graphics Tool,” CCP4 Newsl. Protein Crystallogr 40, no. 1 (2002): 82–92.
  • A. Aljuhani, H.E.A. Ahmed, S.K. Ihmaid, A.M. Omar, S.S. Althagfan, Y.M. Alahmadi, I. Ahmad, H. Patel, S. Ahmed, M.A. Almikhlafi, et al. “In Vitro and Computational Investigations of Novel Synthetic Carboxamide-Linked Pyridopyrrolopyrimidines with Potent Activity as SARS-CoV-2-MPro Inhibitors,” RSC Advances 12, no. 41 (2022): 26895–26907.
  • S. Release, “3: Desmond Molecular Dynamics System, DE Shaw Research, New York, NY, 2017,” Maestro-Desmond Interoperability Tools (New York, NY: Schrödinger, 2017).
  • M.B. Hammouda, I. Ahmad, A. Hamdi, A. Dbeibia, H. Patel, N. Bouali, W.S. Hamadou, K. Hosni, S. Ghannay, F. Alminderej, et al. “Design, Synthesis, Biological Evaluation and in Silico Studies of Novel 1,2,3-Triazole Linked Benzoxazine-2,4-Dione Conjugates as Potent Antimicrobial, Antioxidant and anti-Inflammatory Agents,” Arabian Journal of Chemistry 15, no. 11 (2022): 104226.
  • W.L. Jorgensen, D.S. Maxwell, and J. Tirado-Rives, “Development and Testing of the OPLS All Atom Force Field on Conformational Energetics and Properties of Organic Liquids,” Journal of the American Chemical Society 118, no. 45 (1996): 11225–11236.
  • I. Ahmad, S.R. Akand, M. Shaikh, R. Pawara, S.N. Manjula, and H. Patel, “Synthesis, Molecular Modelling Study of the Methaqualone Analogues as anti-Convulsant Agent with Improved Cognition Activity and Minimized Neurotoxicity,” Journal of Molecular Structure 1251 (2022): 131972.
  • G. Kalibaeva, M. Ferrario, and G. Ciccotti, “Constant Pressure-Constant Temperature Molecular Dynamics: A Correct Constrained NPT Ensemble Using the Molecular Virial,” Molecular Physics 101, no. 6 (2003): 765–778.
  • K. Rakesh, A. Iqrar, P. Harun, K. Vipin, and R. Kaisar, “Phytochemicals from Amberboa Ramosa as Potential DPP-IV Inhibitors for the Management of Type-II Diabetes Mellitus: Inferences from in-Silico Investigations,” Journal of Molecular Structure (2022) 134045.
  • R. Girase, I. Ahmad, R. Pawara, and H. Patel, “Optimizing Cardio, Hepato and Phospholipidosis Toxicity of the Bedaquiline by Chemoinformatics and Molecular Modelling Approach,” SAR and QSAR in Environmental Research 33, no. 3 (2022): 215–235.
  • G. Shi, L. Rao, H. Yu, H. Xiang, G. Pen, S. Long, and C. Yang, “Yeast-Cell-Based Microencapsulation of Chlorogenic Acid as a Water-Soluble Antioxidant,” Journal of Food Engineering 80, no. 4 (2007): 1060–1067.
  • R.P. Dubey, U.H. Patel, S.B. Pandya, K.P. Chaudhary, and B.N. Socha, “Cadmium Complex of Sulfathiazole Dihydrate with Secondary Ligand Pyridine: Structure, DFT Studies, Hirshfeld Surface Analysis and Antimicrobial Activity,” Indian Journal of Physics 95, no. 1 (2021): 33–42.
  • E.C. Agwamba, A.D. Udoikono, H. Louis, E.U. Udoh, I. Benjamin, A.T. Igbalagh, H.O. Edet, E.U. Ejiofor, and U.B. Ushaka, “Synthesis, Characterization, DFT Studies, and Molecular Modeling of Azo Dye Derivatives as Potential Candidate for Trypanosomiasis Treatment,” Chemical Physics Impact 4 (2022): 100076.
  • Z. Zara, J. Iqbal, K. Ayub, M. Irfan, A. Mahmood, R.A. Khera, and B. Eliasson, “A Comparative Study of DFT Calculated and Experimental UV/Visible Spectra for Thirty Carboline and Carbazole Based Compounds,” Journal of Molecular Structure 1149 (2017): 282–298.
  • C.S. Abraham, S. Muthu, J.C. Prasana, S. Armaković, S.J. Armaković, F. Rizwana, B. Geoffrey, and H.A. David, “Computational Evaluation of the Reactivity and Pharmaceutical Potential of an Organic Amine: A DFT, Molecular Dynamics Simulations and Molecular Docking Approach,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 222 (2019): 117188.
  • E.C. Agwamba, I. Benjamin, H. Louis, A.D. Udoikono, A.T. Igbalagh, T.C. Egemonye, and A.S. Adeyinka, “Antitubercolusic Potential of Amino-(Formylphenyl) Diazenyl-Hydroxyl and Nitro-Substituted Naphthalene-Sulfonic Acid Derivatives: Experimental and Theoretical Investigations,” Chemistry Africa 5, no. 5 (2022): 1451–1467.
  • S. Muthu, J.U. Maheswari, and T. Sundius, “Quantum Mechanical, Spectroscopic Studies (FT-IR, FT-Raman, NMR, UV) and Normal Coordinates Analysis on 3-([2-(Diaminomethyleneamino) Thiazol-4-yl] Methylthio)-N′-Sulfamoylpropanimidamide,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 108 (2013): 307–318.
  • F.C. Asogwa, E.C. Agwamba, H. Louis, M.C. Muozie, I. Benjamin, T.E. Gber, G.E. Mathias, A.S. Adeyinka, and A.I. Ikeuba, “Structural Benchmarking, Density Functional Theory Simulation, Spectroscopic Investigation and Molecular Docking of N-(1H-Pyrrol-2-yl) Methylene)-4-Methylaniline as Castration-Resistant Prostate Cancer Chemotherapeutic Agent,” Chemical Physics Impact 5 (2022): 100091.
  • E.I. Paulraj and S. Muthu, “Spectroscopic Studies (FTIR, FT-Raman and UV), Potential Energy Surface Scan, Normal Coordinate Analysis and NBO Analysis of (2R, 3R, 4R, 5S)-1-(2-Hydroxyethyl)-2-(Hydroxymethyl) Piperidine-3, 4, 5-Triol by DFT Methods,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 108 (2013): 38–49.
  • E.A. Eno, J.I. Mbonu, H. Louis, F.S. Patrick-Inezi, T.E. Gber, T.O. Unimuke, E.E.D. Okon, I. Benjamin, and O.E. Offiong, “Antimicrobial Activities of 1-Phenyl-3-Methyl-4-Trichloroacetyl-Pyrazolone: Experimental, DFT Studies, and Molecular Docking Investigation,” Journal of the Indian Chemical Society 99, no. 7 (2022): 100524.
  • M.H. Rahuman, S. Muthu, B.R. Raajaraman, M. Raja, and H. Umamahesvari, “Investigations on 2-(4-Cyanophenylamino) Acetic Acid by FT-IR, FT-Raman, NMR and UV-Vis Spectroscopy, DFT (NBO, HOMO-LUMO, MEP and Fukui Function) and Molecular Docking Studies,” Heliyon 6, no. 9 (2020): E 04976.
  • C.G. Apebende, P.S. Idante, H. Louis, U.S. Ameuru, T.O. Unimuke, T.E. Gber, E.A. Agwamba, I. Benjamin, and F.C. Asogwa, “Integrated Spectroscopic, Bio-Active Prediction and Analytics of Isoquinoline Derivative for Breast Cancer Mitigation,” Chemistry Africa 5, no. 6 (2022): 1979–1995.
  • S. Muthu and A. Prabhakaran, “Vibrational Spectroscopic Study and NBO Analysis on Tranexamic Acid Using DFT Method,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 129 (2014): 184–192.
  • E.A. Eno, H. Louis, P. Ekoja, I. Benjamin, S.A. Adalikwu, M.M. Orosun, T.O. Unimuke, F.C. Asogwa, and E.C. Agwamba, “Experimental and Computational Modeling of the Biological Activity of Benzaldehyde Sulphur Trioxide as a Potential Drug for the Treatment of Alzheimer Disease,” Journal of the Indian Chemical Society 99, no. 7 (2022): 100532.
  • E.C. Agwamba, H. Louis, I. Benjamin, C.G. Apebende, T.O. Unimuke, H.O. Edet, A. Udoikono, A.D. Nwagu, and A.S. Adeyinka, “3-nitrophenyl) Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking Investigations,” Chemistry Africa 5, no. 6 (2022): 2131–2147.
  • T.E. Gber, H. Louis, A.E. Owen, B.E. Etinwa, I. Benjamin, F.C. Asogwa, M.M. Orosun, and E.A. Eno, “Heteroatoms (Si, B, N, and P) Doped 2D Monolayer MoS 2 for NH 3 Gas Detection,” RSC Advances 12, no. 40 (2022): 25992–26010.
  • J. Makhlouf, H. Louis, I. Benjamin, E. Ukwenya, A. Valkonen, and W. Smirani, “Single Crystal Investigations, Spectral Analysis, DFT Studies, Antioxidants, and Molecular Docking Investigations of Novel Hexaisothiocyanato Chromate Complex,” Journal of Molecular Structure 1272 (2023): 134223.
  • I. Benjamin, T.E. Gber, H. Louis, T.N. Ntui, E.I. Oyo-Ita, T.O. Unimuke, M.M. Edim, and A.S. Adeyinka, “Modelling of Aminothiophene-Carbonitrile Derivatives as Potential Drug Candidates for Hepatitis B and C,” Iranian Journal of Science and Technology, Transactions A: Science 46, no. 5 (2022): 1399–1412.
  • T.N. Ntui, E.E. Oyo-Ita, J.A. Agwupuye, I. Benjamin, I.J. Eko, E.I. Ubana, K.M. Etiowo, E.C. Eluwa, and A. Imojara, “Synthesis, Spectroscopic, DFT Study, and Molecular Modeling of Thiophene-Carbonitrile against Enoyl-ACP Reductase Receptor,” Chemistry Africa 6, no. 2 (2023): 945–966.
  • C. Gharbi, H. Louis, I.O. Amodu, I. Benjamin, W. Fujita, C.B. Nasr, and L. Khedhiri, “Crystal Structure Analysis, Magnetic Measurement, DFT Studies, and Adsorption Properties of Novel 1-(2, 5-Dimethyphenyl) Piperazine Tetrachlorocobaltate Hydrate,” Materials Today Communications 34 (2023): 104965.
  • D.I. Ugwu, F.C. Asogwa, S.G. Olisaeloka, J.A. Ezugwu, S.C. Ogbuke, I. Benjamin, H. Louis, T.E. Gber, M.C. Ugwu, F.U. Eze, et al. “Anti-Hypertensive Properties of 2-[N-(4-Methylbenzenesulfonyl)-1-Phenylformamido]-n-(4-Nitrophenyl)-3-Phenylpropenamide: Experimental and Theoretical Studies,” Chemical Physics Impact 6 (2023): 100158.
  • A. Gannouni, H. Louis, T. Roisnel, B.B. Isang, I. Benjamin, and R. Kefi, “X-Ray Crystallography, Spectral Analysis, DFT Studies, and Molecular Docking of (C9H15N3)[CdCl4] Hybrid Material against Methicillin-Resistant Staphylococcus aureus (MRSA),” Polycyclic Aromatic Compounds (2023): 1–23.
  • S.W. Qader, A. Suvitha, M. Ozdemir, I. Benjamin, A.S.R. Nsa, M.U. Akem, A.E. Frank, and E.C. Eluwa, “Investigating the Physicochemical Properties and Pharmacokinetics of Curcumin Employing Density Functional Theory and Gastric Protection,” Chemical Physics Impact 5 (2022): 100130.
  • K. Chukwuemeka, H. Louis, I. Benjamin, P.A. Nyong, E.U. Ejiofor, E.A. Eno, and A.L.E. Manicum, “Therapeutic Potential of B12N12-X (X = Au, Os, and Pt) Nanostructured as Effective Fluorouracil (5Fu) Drug Delivery Materials,” ACS Applied Bio Materials 6, no. 3 (2023): 1146–1160.
  • I. Benjamin, H. Louis, A.D. Udoikono, E.C. Agwamba, T.O. Unimuke, and E.F. Ahuekwe, “Hydrazineylidene‐3‐Oxopropanal Derivatives as Antiviral Agents for Treatment of HBV and HCV: experimental, DFT, and Molecular Docking Studies,” Vietnam Journal of Chemistry 61, no. 1 (2023): 109–125.
  • J. Makhlouf, H. Louis, I. Benjamin, B.B. Isang, C.F. Fidelis, A. Valkonen, and W. Smirani, “Investigation on the Molecular, Electronic, Biological and Spectroscopic Properties of a Novel Cobalt Complex: An Intuition from an Experimental and Computational Perspective,” Polyhedron 235 (2023): 116369.
  • A.D. Udoikono, E.C. Agwamba, H. Louis, I. Benjamin, I. Ahmad, E.U. Ejiofor, E.F. Ahuekwe, K. Chukwuemeka, A.S. Adeyinka, H.M. Patel, et al. “Anti-Inflammatory Biomolecular Activity of Chlorinated-Phenyldiazenyl-Naphthalene-2-Sulfonic Acid Derivatives: Perception from DFT, Molecular Docking, and Molecular Dynamic Simulation,” Journal of Biomolecular Structure and Dynamics (2022): 1–25
  • I. Benjamin, H. Louis, F.O. Ekpen, T.E. Gber, M.E. Gideon, I. Ahmad, T.O. Unimuke, N.P. Akanimo, H. Patel, I.J. Eko, et al. “Modeling the anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Activity of (E)-6-chloro-N2-phenyl-N4-(4-Phenyl-5-(Phenyl Diazinyl)-2λ3, 3 λ2-Thiazol-2-yl)-1, 3, 5-Triazine-2, 4-Diamine,” Polycyclic Aromatic Compounds (2022): 1–28.
  • W. Wei, S. Cherukupalli, L. Jing, X. Liu, and P. Zhan, “Fsp3: A New Parameter for Drug-Likeness,” Drug Discovery Today 25, no. 10 (2020): 1839–1845.
  • P. Ertl, B. Rohde, and P. Selzer, “Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties,” Journal of Medicinal Chemistry 43, no. 20 (2000): 3714–3717.
  • A. Daina, O. Michielin, and V. Zoete, “iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach,” Journal of Chemical Information and Modeling 54, no. 12 (2014): 3284–3301.
  • M. Saber-Ayad, S. Hammoudeh, E. Abu-Gharbieh, R. Hamoudi, H. Tarazi, T.H. Al-Tel, and Q. Hamid, “Current Status of Baricitinib as a Repurposed Therapy for COVID-19,” Pharmaceuticals 14, no. 7 (2021): 680.
  • S.A. Wildman and G.M. Crippen, “Prediction of Physicochemical Parameters by Atomic Contributions,” Journal of Chemical Information and Computer Sciences 39, no. 5 (1999): 868–873.
  • C.A. Lipinski, F. Lombardo, B.W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 23, no. 1–3 (1997): 3–25.
  • I. Moriguchi, S. Hirono, Q. Liu, I. Nakagome, and Y. Matsushita, “Simple Method of Calculating Octanol/Water Partition Coefficient,” Chemical and Pharmaceutical Bulletin 40, no. 1 (1992): 127–130.
  • I. Moriguchi, S. Hirono, I. Nakagome, and H. Hirano, “Comparison of Reliability of Log P Values for Drugs Calculated by Several Methods,” Chemical and Pharmaceutical Bulletin 42, no. 4 (1994): 976–978.
  • J.S. Delaney, “ESOL: estimating Aqueous Solubility Directly from Molecular Structure,” Journal of Chemical Information and Computer Sciences 44, no. 3 (2004): 1000–1005.
  • J. Ali, P. Camilleri, M.B. Brown, A.J. Hutt, and S.B. Kirton, “In Silico Prediction of Aqueous Solubility Using Simple QSPR Models: The Importance of Phenol and Phenol-like Moieties,” Journal of Chemical Information and Modeling 52, no. 11 (2012): 2950–2957.
  • R.O. Potts and R.H. Guy, “Predicting Skin Permeability,” Pharmaceutical Research 9, no. 5 (1992): 663–669.
  • Y.C. Martin, “A Bioavailability Score,” Journal of Medicinal Chemistry 48, no. 9 (2005): 3164–3170.
  • J.B. Baell and G.A. Holloway, “New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays,” Journal of Medicinal Chemistry 53, no. 7 (2010): 2719–2740.
  • R. Brenk, A. Schipani, D. James, A. Krasowski, I.H. Gilbert, J. Frearson, and P.G. Wyatt, “Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases,” ChemMedChem 3, no. 3 (2008): 435–444.
  • S.J. Teague, A.M. Davis, P.D. Leeson, and T. Oprea, “The Design of Leadlike Combinatorial Libraries,” Angewandte Chemie International Edition 38, no. 24 (1999): 3743–3748.
  • M. Sadeghi, M. Moradi, H. Madanchi, and B. Johari, “In Silico Study of Garlic (Allium Sativum L.)-Derived Compounds Molecular Interactions with α-Glucosidase,” In Silico Pharmacology 9, no. 1 (2021): 1–8.
  • E.A. Eno, F.A. Patrick-Inezi, H. Louis, T.E. Gber, T.O. Unimuke, E.C. Agwamba, O.J. Ikenyirimba, J.A. Akpanke, E. Oyoita, E.U. Ejiofor, et al. “Theoretical Investigation and Antineoplastic Potential of Zn (II) and Pd (II) Complexes of 6-Methylpyridine-2-carbaldehyde-N (4)-Ethylthiosemicarbazone,” Chemical Physics Impact 5 (2022): 100094.
  • H.A. Radwan, I. Ahmad, I.M. Othman, M.A. Gad-Elkareem, H. Patel, K. Aouadi, M. Snoussi, and A. Kadri, “Design, Synthesis, in Vitro Anticancer and Antimicrobial Evaluation, SAR Analysis, Molecular Docking and Dynamic Simulation of New Pyrazoles, Triazoles and Pyridazines Based Isoxazole,” Journal of Molecular Structure 1264 (2022): 133312.
  • L.G. Nicely, R.M. Vala, D.B. Upadhyay, J. Nogales, C. Chi, S. Banerjee, and H.M. Patel, (2022). One-Pot Two-Step Catalytic Synthesis of Rationally Designed 6-amino-2-pyridone-3, 5-Dicarbonitriles Enabling Anti-Cancer Bioactivity.
  • R.M. Vala, V. Tandon, L.G. Nicely, L. Guo, Y. Gu, S. Banerjee, and H.M. Patel, “Synthesis of N-(4-Chlorophenyl) Substituted Pyrano [2, 3-c] Pyrazoles Enabling PKBb/AKT2 Inhibitory and in Vitro anti-Glioma Activity,” Annals of Medicine 54, no. 1 (2022): 2549–2561.
  • J. Shaya, S. Kato, J.J. Adashek, H. Patel, P.T. Fanta, G.P. Botta, J.K. Sicklick, and R. Kurzrock, “Personalized Matched Targeted Therapy in Advanced Pancreatic Cancer: A Pilot Cohort Analysis,” NPJ Genomic Medicine 8, no. 1 (2023): 1.
  • I. Ahmad, R.H. Pawara, R.T. Girase, A.Y. Pathan, V.R. Jagatap, N. Desai, Y.O. Ayipo, S.J. Surana, and H. Patel, “Synthesis, Molecular Modeling Study, and Quantum-Chemical-Based Investigations of Isoindoline-1, 3-Diones as Antimycobacterial Agents,” ACS Omega 7, no. 25 (2022): 21820–21844.
  • Y. Boulaamane, I. Ahmad, H. Patel, N. Das, M.R. Britel, and A. Maurady, “Structural Exploration of Selected C6 and C7-Substituted Coumarin Isomers as Selective MAO-B Inhibitors,” Journal of Biomolecular Structure and Dynamics 41, no. 6 (2023): 2326–2340.
  • B. Chaudhari, H. Patel, S. Thakar, I. Ahmad, and D. Bansode, “Optimizing the Sunitinib for Cardio-Toxicity and Thyro-Toxicity by Scaffold Hopping Approach,” In Silico Pharmacology 10, no. 1 (2022 Jul 2): 10.
  • M.M. Farhan, M.A. Guma, M.A. Rabeea, I. Ahmad, and H. Patel, “Synthesizes, Characterization, Molecular Docking and in Vitro Bioactivity Study of New Compounds Containing Triple Beta Lactam Rings,” Journal of Molecular Structure 1269 (2022): 133781.
  • S. Ghosh, S. Das, I. Ahmad, and H. Patel, “In Silico Validation of anti-Viral Drugs Obtained from Marine Sources as a Potential Target against SARS-CoV-2 Mpro,” Journal of the Indian Chemical Society 98, no. 12 (2021): 100272.
  • U. Acar Çevik, I. Celik, A. Işık, I. Ahmad, H. Patel, Y. Özkay, and Z.A. Kaplancıklı, “Design, Synthesis, Molecular Modeling, DFT, ADME and Biological Evaluation Studies of Some New 1,3,4-Oxadiazole Linked Benzimidazoles as Anticancer Agents and Aromatase Inhibitors,” Journal of Biomolecular Structure & Dynamics (2022): 1–15.
  • M.A. Abdelgawad, J.M. Oh, D.G.T. Parambi, S. Kumar, A. Musa, M.M. Ghoneim, A.A. Nayl, A.H. El-Ghorab, I. Ahmad, H. Patel, et. al. “Development of Bromo- and Fluoro-Based α, β-Unsaturated Ketones as Highly Potent MAO-B Inhibitors for the Treatment of Parkinson’s Disease,” Journal of Molecular Structure 1266 (2022): 133545.
  • M.S. Tople, N.B. Patel, P.P. Patel, A.C. Purohit, I. Ahmad, and H. Patel, “An in Silico-in Vitro Antimalarial and Antimicrobial Investigation of Newer 7- Chloroquinoline Based Schiff-Bases,” Journal of Molecular Structure 1271 (2023): 134016.
  • N.C. Desai, S.B. Joshi, A.G. Khasiya, D.J. Jadeja, H.K. Mehta, M. Pandya, I. Ahmad, and H. Patel, “Pyrazolo-Imidazolidinones: Synthesis, Antimicrobial Assessment and Molecular Modelling Studies by Molecular Mechanic and Quantum Mechanic Approach,” Journal of Molecular Structure 1270 (2022): 134000.
  • K.K. Bharadwaj, I. Ahmad, S. Pati, A. Ghosh, T. Sarkar, B. Rabha, H. Patel, D. Baishya, H.A. Edinur, Z. Abdul Kari, et al. “Potent Bioactive Compounds from Seaweed Waste to Combat Cancer through Bioinformatics Investigation,” Frontiers in Nutrition 9 (2022): 889276.
  • Y.O. Ayipo, I. Ahmad, Y.S. Najib, S.K. Sheu, H. Patel, and M.N. Mordi, “Molecular Modelling and Structure-Activity Relationship of a Natural Derivative of o-Hydroxybenzoate as a Potent Inhibitor of Dual NSP3 and NSP12 of SARS-CoV-2: In Silico Study,” Journal of Biomolecular Structure & Dynamics (2022): 1–19.
  • M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, D.J. Fox, Gaussian 09; Gaussian, Inc, vol. 32 (Wallingford, CT. 2009), 5648–52.
  • B. F. Rizwana, J. C. Prasana, C. S. Abraham, S. Muthu, “Spectroscopic investigation, hirshfeld surface analysis and molecular docking studies on anti-viral drug entecavir,” Journal of Molecular Structure, 1164, (2018): 447–458.
  • T. O. Unimuke, H. Louis, W. Emori, P.S. Idante, E. C. Agwamba, I. C. Nwobodo, K. Wei, C-R. Cheng, S. A. Adalikwu, V. M. Bassey, “Spectroscopic and molecular electronic property investigation of 2-phenylpyrimidine-4, 6-diamine via 1H NMR, UV–vis, FT-Raman, FT-IR, and DFT approach,” Journal of Molecular Structure, 1263, (2022): 133195.
  • R. Dubey, A. Gunasekaran, S. J. Childe, T. Papadopoulos, Z. Luo, S. F. Wamba D. Roubaud, “Can big data and predictive analytics improve social and environmental sustainability?,” Technological Forecasting and Social Change, 144, (2019): 534–545.
  • C. L. Briggs, Stories in the Time of Cholera (University of California Press, 2003).
  • C. E. Rosenberg, The cholera years: The United States in 1832, 1849, and 1866 (University of Chicago Press, 2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.